COMMUNIQUÉS West-GlobeNewswire

Aura to Acquire Majority Interest in Israeli Cannabis Retailer in Partnership With Industry Icon Shlomi Sendak
05/09/2018
TORONTO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE: BUZZ ) is very pleased to announce it has entered into a binding term sheet (“ Term Sheet ” or “ Agreement ”) to acquire [...]
Ambu A/S: Major shareholder announcement
05/09/2018
In reference to § 30 and according to § 38 of the Danish Capital Markets Act (Kapitalmarkedsloven), Ambu hereby announces to have received a major shareholder announcement from Chr. Augustinus Fabrikker Akts. On 5 [...]
American College of Rheumatology Releases First-Ever Rheumatic Disease Report Card
05/09/2018
New Report Examines Access, Affordability and Lifestyle Factors Affecting Rheumatic Disease Care in all 50 States and the District of Columbia Atlanta, Sept. 05, 2018 (GLOBE NEWSWIRE) -- The American College of [...]
PSIQ Plans to Become a Fully Reporting SEC Issuer and Uplist to the OTCQB
05/09/2018
SUNRISE, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that Daszcal Bolton, LLP, an independent certified public accountant has completed the audit of PSIQ’s financial [...]
Zosano Pharma and Collaborators to Present Efficacy Data for M207 in the Treatment of Migraine at the 17th Biennial Migraine Trust International Symposium (MTIS)
05/09/2018
FREMONT, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
05/09/2018
CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics ( TASE: ANCN ), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Bespoke Extracts Announces Launch of Wholesale CBD Division, Among Other Key Marketing and Business Developments
05/09/2018
SUNNY ISLES, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced the launch of its newly formed Wholesale [...]
Diversicare Announces Appointment of Kerry D. Massey Executive Vice President and Chief Financial Officer
05/09/2018
BRENTWOOD, Tenn., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) today announced the appointment of Kerry D. Massey as the Company’s Executive Vice President and Chief Financial [...]
Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury
05/09/2018
IRVINE, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the appointment of Ashwin K. Agarwal as Vice President, Finance, Investor [...]
Matinas BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
05/09/2018
Presentation with live audio webcast on Thursday, September 6th at 5:05 PM ET BEDMINSTER, N.J., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical [...]
Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
05/09/2018
LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior [...]
AIT Therapeutics Announces $526,500 Sale of Common Stock To Institutional Investor, Lincoln Park Capital Fund
05/09/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused [...]
Progressive Care Inc. CEO to Speak at First US FlyPharma Conference in Miami, Fla.
05/09/2018
MIAMI, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the [...]
Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina
05/09/2018
--Fast-Tracking Deployment of C3004 Trait into Canola and Soybean WOBURN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change [...]
Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection
05/09/2018
PLYMOUTH MEETING, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today announced the dosing of the first subject with its vaccine to prevent infection from the deadly MERS [...]
Tetra Bio-Pharma Secures CBD Supply Agreement for Genacol Partnership
05/09/2018
ORLEANS, Ontario, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that it has secured a [...]
WishBone Medical, Inc. announces new AlloMate Bone Pin System
05/09/2018
WARSAW, Ind., Sept. 05, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. announces the official launch of the single-use, sterile packed AlloMate Bone Pin System for the maintenance of alignment and fixation of bone [...]
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
05/09/2018
EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer
05/09/2018
MINNEAPOLIS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ” and “ DiaMedica ”) (TSX-V:DMA) (OTCQB:DMCAF) announces the recent appointment of Harry Alcorn Jr. Pharm.D. as Chief Medical [...]

Pages